274901-16-5 Vildagliptin 98%

Cohance Lifesciences is a leading CDMO and API platform, offering products and services across all phases of a molecule’s lifecycle from development to commercialzation. Our Business Units comprise of:

CDMO

With our expertise in complex chemistries, we provide end-to-end CDMO services to global innovators and have delivered numerous projects from concept to commercialization over the years

API+ and Formulations

As a global API player, we serve customers across nearly 60 countries with 80+ molecules backed by robust R&D, regulatory capabilities and manufacturing infrastructure. We are among the top backward integrated exporters of pellets and have strong development and manufacturing capabilities

Clinical and Analytical Services

Through our CR-Bio division, we are leading provider of clinical solutions in the area of Bioavailability & Bioequivalence studies as well as Clinical Trials with a focus on providing quality outcomes to global customers.